10.20
price down icon0.05%   -0.005
after-market 시간 외 거래: 10.20 0.005 +0.05%
loading
전일 마감가:
$10.20
열려 있는:
$10.18
하루 거래량:
42,187
Relative Volume:
0.47
시가총액:
$341.54M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.05%
1개월 성능:
+0.64%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
Value
$10.18
$10.20
1주일 범위
Value
$10.17
$10.20
52주 변동 폭
Value
$9.96
$10.27

Drugs Made In America Acquisition Corp Stock (DMAA) Company Profile

Name
명칭
Drugs Made In America Acquisition Corp
Name
전화
954-870-3104
Name
주소
2 PELICAN DR., FORT LAUDERDALE
Name
직원
0
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
DMAA's Discussions on Twitter

DMAA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Shell Companies icon
DMAA
Drugs Made In America Acquisition Corp
10.20 341.54M 0 0 0 0.00
Shell Companies icon
LION
Lionsgate Studios Corp
5.76 1.91B 2.82B -191.60M -407.10M -0.6794
Shell Companies icon
AACT
Ares Acquisition Corporation Ii
11.31 702.73M 0 16.92M -1.35M 0.29
Shell Companies icon
CCCM
Columbus Circle Capital Corp I
10.52 480.62M 0 0 0 0.00
Shell Companies icon
EQV
Eqv Ventures Acquisition Corp
10.53 468.90M 0 0 0 0.00
Shell Companies icon
ANSC
Agriculture Natural Solutions Acquisition Corp
10.83 465.53M 0 1.30M 0 0.0301

Drugs Made In America Acquisition Corp 주식(DMAA)의 최신 뉴스

pulisher
Jun 10, 2025

Layoff Tracker: National Resilience Closes 60% of Its Manufacturing Footprint - BioSpace

Jun 10, 2025
pulisher
Jun 02, 2025

Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology - TradingView

Jun 02, 2025
pulisher
Jun 01, 2025

Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology - Yahoo Finance

Jun 01, 2025
pulisher
May 31, 2025

Trump says he is doubling tariffs on imported steel to 50% – as it happened - The Guardian

May 31, 2025
pulisher
May 22, 2025

Pfizer Inc. - Britannica

May 22, 2025
pulisher
May 15, 2025

Drugs Made In America Faces 10-Q Filing Delay - TipRanks

May 15, 2025
pulisher
May 05, 2025

PCI Pharma Services Completes Ajinomoto Althea Acquisition - Contract Pharma

May 05, 2025
pulisher
May 01, 2025

Part of $1 Billion Investment Strategy, PCI Pharma Services Completes Acquisition of Ajinomoto Althea, Enhancing US Drug Product Manufacturing for Aseptic Filling of Prefilled Syringes & Cartridges - Business Wire

May 01, 2025
pulisher
Apr 25, 2025

Financial Snapshot: Analyzing East West Bancorp, Inc (EWBC)’s Key Ratio Metrics - DWinneX

Apr 25, 2025
pulisher
Apr 25, 2025

Metric Deep Dive: Understanding Drugs Made In America Acquisition Corp (DMAA) Through its Ratios - DWinneX

Apr 25, 2025
pulisher
Apr 25, 2025

Market Resilience: Four Corners Property Trust Inc (FCPT) Finishes Weak at 27.86, Down -1.90 - DWinneX

Apr 25, 2025
pulisher
Apr 25, 2025

Daily Progress: Coca-Cola Europacific Partners Plc (CCEP) Drop -0.78, Closing at 88.15 - DWinneX

Apr 25, 2025
pulisher
Apr 25, 2025

Financial Analysis: Bio-Key International Inc (BKYI)’s Ratios Unveil Key Insights - DWinneX

Apr 25, 2025
pulisher
Apr 25, 2025

Ratio Revelations: Amerant Bancorp Inc (AMTB)’s Financial Metrics in the Spotlight - DWinneX

Apr 25, 2025
pulisher
Apr 25, 2025

Closing Strong: Lulus Fashion Lounge Holdings Inc (LVLU) Ends at 0.41, Down -7.73 from Last Close - DWinneX

Apr 25, 2025
pulisher
Apr 23, 2025

What's Next for Pfizer After the Company Pulls Its Weight Loss Drug? - Yahoo Finance

Apr 23, 2025
pulisher
Apr 21, 2025

The top 20 pharma companies by 2024 revenue - Fierce Pharma

Apr 21, 2025
pulisher
Apr 20, 2025

AstraZeneca | Pharmaceuticals, Vaccines, & Facts - Britannica

Apr 20, 2025
pulisher
Apr 17, 2025

WEBTOON Entertainment Inc. (NASDAQ:WBTN) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World

Apr 17, 2025
pulisher
Apr 16, 2025

ICR, the Leading SPAC Communications and Advisory Firm, Publishes its Q1 2025 SPAC Market Update & Outlook - Business Wire

Apr 16, 2025
pulisher
Apr 11, 2025

Theratechnologies’ stock soars on disclosure of acquisition offer by U.S. company - Montreal Gazette

Apr 11, 2025
pulisher
Apr 11, 2025

Pharma’s US manufacturing moment: Where companies are making the biggest moves - Pharma Voice

Apr 11, 2025
pulisher
Apr 04, 2025

10 Best Health Care Stocks to Buy for 2025 - US News Money

Apr 04, 2025
pulisher
Apr 02, 2025

After saying overseas drugmakers would have a “big tax to pay,” Trump spares pharmaceuticals from reciprocal tariffs - Sherwood News

Apr 02, 2025
pulisher
Apr 01, 2025

'I bought their dream': How a US company's huge land deal in Senegal went bust - Yahoo

Apr 01, 2025
pulisher
Mar 31, 2025

Drugs Made In America Acquisition Corp. (DMAA) reports earnings - Quartz

Mar 31, 2025
pulisher
Mar 21, 2025

Bright Green Unveils Massive $2B Cannabis Strategy with Zero Shareholder Dilution - StockTitan

Mar 21, 2025
pulisher
Mar 21, 2025

Bright Green Corporation Announces the next steps for the completion of its restructuring plan - The Manila Times

Mar 21, 2025
pulisher
Mar 18, 2025

How TD Became America’s Most Convenient Bank for Money Launderers - Bloomberg.com

Mar 18, 2025
pulisher
Mar 17, 2025

DRUGS MADE IN AMERICA ACQUISITION CORP- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com

Mar 17, 2025
pulisher
Mar 14, 2025

India-based Syngene acquires its first US biologics site - Manufacturing Dive

Mar 14, 2025
pulisher
Mar 13, 2025

Drugmakers Mallinckrodt and Endo get a bump from tariffs in $6.7 billion merger - Reuters

Mar 13, 2025
pulisher
Mar 07, 2025

7 Best Weight Loss Drug Stocks to Buy in 2025 | Investing | U.S. News - U.S News & World Report Money

Mar 07, 2025
pulisher
Mar 05, 2025

Not All Generics Are Created Equal: Study Exposes a 54% Higher Risk in Indian-Made Drugs - SciTechDaily

Mar 05, 2025
pulisher
Mar 03, 2025

Brokerages Set TWFG, Inc. (NASDAQ:TWFG) Target Price at $31.86 - Defense World

Mar 03, 2025
pulisher
Feb 28, 2025

BridgeBio Oncology Therapeutics (BBOT) and Helix Acquisition Corp. II Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing a Pipeline of RAS and PI3Kα-Targeting Medicines - Business Wire

Feb 28, 2025
pulisher
Feb 26, 2025

Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding $50 billion | Eli Lilly and Company - Eli Lilly

Feb 26, 2025
pulisher
Feb 25, 2025

A little-known Chinese company made a drug that beat the world’s biggest-selling medicine - CNN

Feb 25, 2025
pulisher
Feb 24, 2025

Drugs Made in America Acquisition Corp. Forms Advisory Team to Pursue Pharmaceutical Business Acquisitions - Nasdaq

Feb 24, 2025
pulisher
Feb 23, 2025

How Vivek Ramaswamy got rich before going into politics - Cincinnati Enquirer

Feb 23, 2025
pulisher
Feb 22, 2025

Popular cannabis brand declares Chapter 11 bankruptcy - TheStreet

Feb 22, 2025
pulisher
Feb 21, 2025

Fierce Pharma Asia—Novo Nordisk's fraud accusation; AstraZeneca's China deal; Ono's FDA nod - Fierce Pharma

Feb 21, 2025
pulisher
Feb 20, 2025

Drugs Made In America Acquisition Corp. Announces Trading Options for Public Offering Units Starting February 25, 2025 - Nasdaq

Feb 20, 2025
pulisher
Feb 19, 2025

Mink Ventures Completes Acquisition of Warren Ni, Cu, Co Patents - The Manila Times

Feb 19, 2025
pulisher
Feb 18, 2025

Drugs Made In America Acquisition Corp. Announces Closing of Full Exercise of IPO Over-Allotment Option - TradingView

Feb 18, 2025
pulisher
Feb 18, 2025

Drugs Made In America Acquisition Corp. Secures Additional $30 Million in IPO as Underwriter Fully Exercises Overallotment Option - Nasdaq

Feb 18, 2025
pulisher
Feb 13, 2025

U.S. investors, Big Pharma race to find new medicines in China - CNBC

Feb 13, 2025
pulisher
Feb 12, 2025

Drugs Made In America Acquisition Corp.’s $200 Million Initial Public Offering - Global Legal Chronicle

Feb 12, 2025

Drugs Made In America Acquisition Corp (DMAA) 재무 분석

Drugs Made In America Acquisition Corp (DMAA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$10.18
price up icon 0.00%
$11.10
price up icon 0.00%
$11.45
price up icon 1.42%
shell_companies CEP
$27.11
price down icon 2.43%
shell_companies AAM
$10.43
price up icon 0.05%
$10.83
price down icon 0.18%
자본화:     |  볼륨(24시간):